Angela Tamara Rudd Sells 245 Shares of TCBK

Angela Tamara Rudd, the Chief Risk Officer at TCBK, sold 245 shares of the company on June 12, 2026. The transaction was not part of a pre-planned trading program. Shares of TCBK were trading at $51.67 at the time of the sale.

Other Institutional Activity in TCBK

Several institutional investors have recently adjusted their positions in TCBK. FMR LLC reduced its holdings by 32,534 shares, ending with 2,890,248 shares valued at approximately $137.4 million. BlackRock, Inc. also trimmed its stake, selling 21,700 shares to hold 2,392,458 shares worth about $113.7 million. In contrast, Dimensional Fund Advisors LP and Franklin Resources Inc increased their positions, with Dimensional adding 11,298 shares for a total of 1,696,463 shares valued at around $80.6 million, and Franklin acquiring 12,652 shares, bringing its total to 1,649,900 shares valued at $78.4 million.

Insider Buying and Selling at TCBK

In addition to Angela Tamara Rudd's sale, other insider transactions occurred on June 12, 2026. Peter Wiese, EVP Chief Financial Officer, both bought and sold 2,104 shares. Daniel Bailey, EVP Chief Banking Officer, sold 1,608 shares, and Craig Carney, EVP Chief Credit Officer, sold 899 shares at $52.64 each. Jason Todd Levingston, Chief Information Officer, bought 539 shares. These transactions were not conducted under a Rule 10b5-1 plan.

Analysts Set New Price Targets

On April 27, 2026, Piper Sandler maintained its 'buy' rating on TCBK, setting a price target of $63. Previously, on January 26, 2026, Piper Sandler had also maintained a 'buy' rating with a $59 target. Stephens & Co. and Keefe, Bruyette & Woods both maintained a 'buy' and 'hold' rating respectively, with targets at $55. The consensus among analysts is positive, with a mean price target of $55 and multiple analysts recommending a 'buy'.

Bottom Line

Insider sales, like the one made by Angela Tamara Rudd, are closely watched by investors for potential signals about the company's future performance. While insider transactions can provide insight, they are not necessarily indicative of the company's current health or future prospects. TCBK's stock remains under observation by several institutional investors and analysts, with recent adjustments in holdings and maintained ratings reflecting ongoing interest in the company's performance.